4//SEC Filing
MATTINGLY MARTIN A 4
Accession 0001209191-23-025285
CIK 0001394319other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 8:44 PM ET
Size
5.8 KB
Accession
0001209191-23-025285
Insider Transaction Report
Form 4
MATTINGLY MARTIN A
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2023-04-19+18,000→ 18,000 totalExercise: $1.82Exp: 2033-04-18→ Common Stock (18,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest and become exercisable on the earlier of the first anniversary of the grant date set forth in column 3 above or the date of the next annual meeting of the Company's stockholders, subject to the optionee's Continuous Service (as defined in the Company's 2015 Equity Incentive Plan (the "Plan")) and accelerated on the closing of a Change of Control (as defined in the Plan).
Documents
Issuer
Tracon Pharmaceuticals, Inc.
CIK 0001394319
Entity typeother
Related Parties
1- filerCIK 0001265782
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 8:44 PM ET
- Size
- 5.8 KB